How far does a new horizon extend for rucaparib in metastatic prostate cancer?

Transl Cancer Res. 2024 Jan 31;13(1):11-14. doi: 10.21037/tcr-23-1563. Epub 2024 Jan 12.

Authors

Fatima Karzai¹, Ravi A Madan¹, William D Figg¹

Affiliation

¹ Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

No abstract available

Keywords: BRCA; Rucaparib; metastatic; prostate cancer.

Publication types

Editorial
Comment